Acciones Boston Therapeutics, Inc. Other OTC
Acciones
BTHE
US1011501004
Equipo médico y tecnología avanzada
Ventas 2021 | 142 mil 131 mil | Ventas 2022 | 15,45 mil 14,29 mil | Capitalización | 9,32 M 8,62 M |
---|---|---|---|---|---|
Resultado Neto 2021 | -9 M -8,33 M | Resultado Neto 2022 | -12 M -11,1 M | VE / Ventas 2021 | 149 x |
Deuda neta 2021 | 4,52 M 4,18 M | Deuda neta 2022 | 11,39 M 10,54 M | VE / Ventas 2022 | 1.340 x |
P/E ratio 2021 |
-1,75
x | P/E ratio 2022 |
-0,62
x | Empleados | - |
Rendimiento 2021 * |
-
| Rendimiento 2022 |
-
| Flotante | 42,05 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Director of Finance/CFO | - | 19/01/23 | |
Bradley Johnson
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/22 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jerry Fiddler
BRD | Director/Board Member | 72 | - |
Chairman | 69 | - | |
David Ludvigson
CEO | Chief Executive Officer | 74 | - |
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,88 % | 30,39 mil M | |
+38,23 % | 8820,43 M | |
+42,57 % | 4587,94 M | |
-29,79 % | 2639,83 M | |
-9,44 % | 1586,65 M | |
-22,85 % | 1349,69 M | |
-37,12 % | 1076,13 M | |
+10,08 % | 921 M | |
-42,90 % | 799 M |